Arrowgrass Capital Partners (US)’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-44,655	Closed	-$1.21M	–	489
2015 Q4	$1.21M	Buy	+44,655	New	+$1.15M	0.01%	289

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s MR Position: Q1 2016 in Review

Arrowgrass Capital Partners (US) sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 44,655 shares — an estimated $1.21M sold.

Arrowgrass Capital Partners (US) first reported a position in MR in Q4 2015 and held it in 1 quarter. The position peaked at $1.21M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Arrowgrass Capital Partners (US) reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 44,655 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.21M.
Arrowgrass Capital Partners (US) first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2015 and held it in 1 quarter.
Arrowgrass Capital Partners (US)'s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.21M in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2016, filed 16 May 2016.